Skip to main content
Equibles

Sarissa Capital Management LP

Position in INVA — Innoviva, Inc.

CIK 1577524 GREENWICH, CT
Back to INVA Full portfolio

Position in INVA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$42,935,616
-$6,715,519 QoQ
Shares Held
1,890,604
-11.3% QoQ
Ownership
2.62%
of shares outstanding
% of Portfolio
24.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INVA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Sarissa Capital Management LP holds $74,157,038 across 5 Biotechnology names. INVA ranks #1 (57.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INVA
Innoviva, Inc.
This page 		1,890,604 $42,935,616
2 CYTK
Cytokinetics Inc
 228,623 $19,476,393
3 BHVN
Biohaven Ltd.
 582,312 $8,664,802
4 REGN
Regeneron Pharmaceuticals, Inc.
 4,190 $2,612,632
5 VOR
Vor Biopharma Inc.
 25,399 $467,595

All Filings in INVA

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $42,935,616 1,890,604
2026-03-31 $49,651,135 2,130,950
2025-12-31 $56,292,279 2,816,022
2025-09-30 $51,392,401 2,816,022
2025-06-30 $56,573,881 2,816,022
2025-03-31 $51,054,478 2,816,022
2024-12-31 $126,255,950 7,277,000
2024-09-30 $140,518,870 7,277,000
2024-06-30 $119,342,800 7,277,000
2024-03-31 $110,901,480 7,277,000
2023-12-31 $116,723,080 7,277,000
2023-09-30 $94,528,230 7,277,000
2023-06-30 $92,636,210 7,277,000
2023-03-31 $74,407,500 6,614,000
2022-12-31 $87,635,500 6,614,000
2022-09-30 $76,788,540 6,614,000
2022-06-30 $97,622,640 6,614,000
2022-03-31 $127,980,900 6,614,000
2021-12-31 $114,091,500 6,614,000
2021-09-30 $110,519,940 6,614,000
2021-06-30 $86,011,740 6,414,000
2021-03-31 $76,647,300 6,414,000
2020-12-31 $79,469,460 6,414,000
2020-09-30 $67,026,300 6,414,000
2020-06-30 $89,667,720 6,414,000
2020-03-31 $73,405,920 6,242,000